🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this long term extension study is to assess safety, tolerabi...
Status
Terminated
Location
Meitetsu Hospital
Start Date
2010-12
Trial ID
NCT01238991
The purpose of this study is to assess the safety, tolerability, and immuno...
Status
Completed
Location
Tazuke Kofukai Medical Research Institute Kitano Hospital
Start Date
2009-08
Trial ID
NCT00959192
The study is to evaluate the safety, tolerability and whether there is an i...
Status
Completed
Location
Suwa Red Cross Hospital
Start Date
2008-12
Trial ID
NCT00752232
The purpose of this study is to assess the long term safety, tolerability, ...
Status
Terminated
Location
Banner Alzheimer's Institute
Start Date
2009-07
Trial ID
NCT00960531
Treatments Being Tested
To assess the safety, tolerability, and immunogenicity of ACC-001, an inves...
Status
Completed
Location
Groupe Hospitalier Pitie-Salpetriere
Start Date
2007-05
Trial ID
NCT00479557
Treatments Being Tested
The purpose of this study is to assess the long term safety, tolerability, ...
Status
Completed
Location
CMRR Bordeaux CHU Pellegrin
Start Date
2009-11-05
Trial ID
NCT00955409
Treatments Being Tested
A Phase II clinical research study to evaluate the efficacy and safety of t...
Status
Completed
Location
Janssen AI Investigational Site
Start Date
2011-01
Trial ID
NCT01284387
Treatments Being Tested
This study in individuals with early Alzheimer's disease is designed to ass...
Status
Completed
Location
Banner Alzheimer's Institute
Start Date
2011-02
Trial ID
NCT01227564
Treatments Being Tested
To access the safety, tolerability, and immunogenicity of ACC-001, an inves...
Status
Completed
Location
Banner Alzheimer's Institute
Start Date
2007-11
Trial ID
NCT00498602
Treatments Being Tested